|
Market Closed -
Sao Paulo
00:21:25 19/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 86.64 BRL | -85.05% |
|
+1.69% | +10.74% |
| 08-12 | Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says | MT |
| 08-11 | Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.60% | +0.88% | +3.95% | +24.05% | +14.06% | +75.59% | +124.32% | +356.48% | +1,436.39% | 1,093B | |
| +3.33% | +4.35% | +7.14% | +18.43% | +31.00% | +53.82% | +57.17% | +53.01% | +124.58% | 653B | |
| +3.43% | +3.53% | +1.74% | +23.64% | +13.32% | +25.34% | +72.45% | +120.75% | +287.78% | 458B | |
| +1.35% | -2.17% | +7.99% | +12.19% | +9.96% | +40.98% | +41.50% | -3.13% | +48.27% | 355B | |
| +1.75% | -0.24% | +0.45% | +7.13% | +14.56% | +25.28% | +40.46% | +44.74% | +60.05% | 294B | |
| +2.13% | -0.32% | -6.26% | -13.89% | -14.39% | +0.58% | +10.77% | +35.20% | +133.97% | 248B | |
| +1.41% | +2.65% | +16.10% | +31.10% | +29.93% | +45.34% | +62.43% | +87.48% | +143.36% | 230B | |
| +1.35% | -3.53% | -10.17% | +3.62% | -8.89% | -14.72% | -52.63% | -11.46% | +91.50% | 203B | |
| +3.25% | +5.65% | +6.82% | +10.62% | +16.86% | +21.57% | +89.04% | +99.33% | +77.99% | 178B | |
| +1.41% | +2.37% | +8.78% | +7.58% | +9.44% | +8.70% | -25.67% | -44.74% | -22.56% | 155B | |
| +2.20% | +3.84% | +8.74% | +15.25% | +22.45% | +37.06% | +6.43% | -2.77% | +12.56% | 135B | |
| +2.45% | -0.28% | +8.76% | +20.98% | +16.51% | +35.48% | +53.18% | +171.19% | +432.99% | 134B | |
| +1.32% | +3.01% | +0.43% | +4.48% | -6.10% | -9.24% | -20.74% | -13.36% | +10.69% | 108B | |
| +1.97% | -0.42% | -1.49% | +0.61% | +3.48% | +31.20% | +39.96% | -1.01% | -9.80% | 102B | |
| +0.26% | -4.40% | -7.15% | -13.46% | -16.68% | +5.03% | +62.44% | +59.68% | +531.06% | 70.58B | |
| +0.70% | +3.29% | +3.42% | +9.32% | +18.82% | +27.33% | +30.93% | +56.41% | +26.82% | 57.04B | |
| +1.75% | -0.43% | +0.58% | +28.84% | +31.69% | +76.15% | -3.14% | +1.72% | -49.65% | 55.44B | |
| -0.95% | -4.73% | -1.54% | -0.11% | -12.09% | -16.98% | +31.09% | -4.76% | +217.17% | 51.19B | |
| +0.33% | +0.27% | +14.21% | +7.49% | +17.21% | +102.55% | +282.64% | +287.50% | -31.05% | 42.63B | |
| Average | +1.60% | -0.12% | +3.29% | +10.41% | +10.06% | +30.06% | +47.51% | +68.01% | +185.37% | 243.24B | |
| Weighted average by Cap. | +2.49% | +0.23% | +3.87% | +15.14% | +13.46% | +40.17% | +60.71% | +123.15% | +436.67% |
- Stock Market
- Stocks
- VRTX Stock
- VRTX34 Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
